1. Home
  2. IPGP vs GPCR Comparison

IPGP vs GPCR Comparison

Compare IPGP & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IPG Photonics Corporation

IPGP

IPG Photonics Corporation

HOLD

Current Price

$120.73

Market Cap

5.5B

Sector

Technology

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$58.09

Market Cap

6.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPGP
GPCR
Founded
1990
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
6.3B
IPO Year
2000
2023

Fundamental Metrics

Financial Performance
Metric
IPGP
GPCR
Price
$120.73
$58.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
11
Target Price
$122.17
$104.64
AVG Volume (30 Days)
715.8K
770.4K
Earning Date
05-14-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
117.85
N/A
EPS
0.73
N/A
Revenue
$1,003,777,000.00
N/A
Revenue This Year
$7.39
N/A
Revenue Next Year
$11.50
N/A
P/E Ratio
$173.88
N/A
Revenue Growth
2.73
N/A
52 Week Low
$48.59
$13.24
52 Week High
$155.82
$94.90

Technical Indicators

Market Signals
Indicator
IPGP
GPCR
Relative Strength Index (RSI) 50.31 27.01
Support Level $73.73 $18.36
Resistance Level $141.43 $93.91
Average True Range (ATR) 9.77 3.19
MACD -2.86 -1.03
Stochastic Oscillator 0.71 7.02

Price Performance

Historical Comparison
IPGP
GPCR

About IPGP IPG Photonics Corporation

IPG Photonics Corp is a vertically integrated developer and manufacturer of high-performance fiber lasers, laser and non-laser systems, fiber amplifiers, diode lasers, and related optical components. Its products are used in diverse applications in the manufacturing, automotive, industrial, aerospace, semiconductor, and consumer end markets. The company sells its products globally to original equipment manufacturers (OEMs), system integrators, and end users. Additionally, it manufactures complementary products used with its lasers, including optical delivery cables, fiber couplers, beam switches, optical processing heads, in-line sensors, and chillers. Geographically, the company generates maximum revenue from North America, followed by China, Japan, Germany, and other markets.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: